A revolutionary, cutting-edge cure is promising hope for millions of cancer patients in India. CAR-T therapy, developed by Dr Gaurav Narula and his team of doctors, is now commercially available in India in just under Rs 50 lakh, as compared to its Rs 4 crore price tag in the US.